This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
An index measures a segment of the stock market, aggregating prices or returns. Learn what it reveals about market trends.
27,998 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
A major investment manager recently disclosed a sizable position in Varonis Systems. This article unpacks what the mo...
This deep dive analyzes the poci 2026 earnings transcript, translating quarterly numbers into real-world implications...
When top executives trim stakes, investors take note. This article breaks down the meaning behind such moves, with a ...
AMD has delivered a staggering run, rising nearly 300% over past year. This article breaks down whether the momentum ...
Investors are weighing a 32% drop in Netflix stock since April after Reed Hastings signaled a board exit. Here’s how ...
Smart investors don't chase the highest yield. They look for dividend growth, sustainable payouts, and strong cash fl...
Pinterest sparked a noticeable stock move after its Q1 results, but a single quarter rarely writes the full comeback ...
A quiet, strategic move by a bank’s wealth management arm adds more exposure to its parent company’s stock. Learn wha...
Block is pushing a bold crypto-backed play inside its fintech ecosystem. This article breaks down what the move could...
Two heavyweight paths in AI CPUs shape the next decade of computing. This article breaks down how Advanced Micro Devi...
Bitcoin briefly peaked above $69k this week before pulling back toward $65k as equity markets turned lower and gold c...